Ferritin as a diagnostic, differential diagnostic, and prognostic marker for immune-related adverse events
Objective: Distinguishing immune-related adverse events (irAEs) caused by immune checkpoint inhibitors (ICIs) from the AEs caused by chemotherapy, targeted therapy, or infection is highly difficult. This study offers new insights into evaluating the diagnosis, differential diagnostic, and prognostic...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
China Anti-Cancer Association
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/1f35fc1f305e4dacbf38d508d4a1651f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|